Cargando…

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia

One of the most promising approaches to preventing relapse is the stimulation of the body’s own immune system to kill residual cancer cells after conventional therapy has destroyed the bulk of the tumour. In acute myeloid leukaemia (AML), the high frequency with which patients achieve first remissio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Ghazala Naz, Orchard, Kim, Guinn, Barbara-ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406328/ https://www.ncbi.nlm.nih.gov/pubmed/30678059 http://dx.doi.org/10.3390/jcm8020134

Ejemplares similares

microRNA expression in acute myeloid leukaemia: New targets for therapy?
por: Fletcher, Daniel, et al.
Publicado: (2022)

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
por: Jordaens, Stephanie, et al.
Publicado: (2020)

Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia
por: Davis, Lindsay, et al.
Publicado: (2020)

Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022)

A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis
por: Morris, Vanessa S., et al.
Publicado: (2023)

Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients
por: Greiner, Jochen, et al.
Publicado: (2021)

Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia
por: Guinn, Barbara-ann, et al.
Publicado: (2007)

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
por: Casirati, Gabriele, et al.
Publicado: (2023)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Publicado: (1978)

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis
por: Brooks, Suzanne E., et al.
Publicado: (2015)

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
por: Boullosa, Laurie Freire, et al.
Publicado: (2017)

Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
por: Khan, Ghazala, et al.
Publicado: (2015)

The rocky road to personalized medicine in acute myeloid leukaemia
por: Brinda, Bryan, et al.
Publicado: (2018)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Acute Myeloid Leukaemia: New Targets and Therapies
por: Brown, Geoffrey, et al.
Publicado: (2017)

Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?
por: Grayson, Kelly, et al.
Publicado: (2019)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
por: Taylor, G. M., et al.
Publicado: (1976)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
por: Chin, Lynn, et al.
Publicado: (2023)

Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia
por: Kadowaki, Norimitsu, et al.
Publicado: (2011)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà, Giovanna, et al.
Publicado: (2019)

The power and potential of integrated diagnostics in acute myeloid leukaemia
por: Haferlach, Torsten, et al.
Publicado: (2019)

The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

The Frequency of Aberrant CD7 Antigen Expression in Acute Myeloid Leukaemia Patients
por: Raza, Hassan, et al.
Publicado: (2022)

N6-Methyladenosine Role in Acute Myeloid Leukaemia
por: Ianniello, Zaira, et al.
Publicado: (2018)

SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
por: Voisset, Edwige, et al.
Publicado: (2020)

Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
por: Grove, Carolyn S., et al.
Publicado: (2014)

Polycomb Alterations in Acute Myeloid Leukaemia: From Structure to Function
por: Bhattacharyya, Teerna, et al.
Publicado: (2023)

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
por: Humphries, Sam, et al.
Publicado: (2023)

Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia
por: Skelding, Kathryn A., et al.
Publicado: (2022)

Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
por: Summerfield, G. P., et al.
Publicado: (1979)

Outcome of acute myeloid leukaemia in Nigeria: clinician’s perspective
por: Ogbenna, Ann Abiola, et al.
Publicado: (2021)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ov4p90u79707jeujgus9199fjl